tiprankstipranks
Trending News
More News >
Tenon Medical, Inc. (TNON)
NASDAQ:TNON
US Market

Tenon Medical, Inc. (TNON) Earnings Dates, Call Summary & Reports

Compare
215 Followers

Earnings Data

Report Date
Aug 06, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.47
Last Year’s EPS
-8.16
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 13, 2025
|
% Change Since: -12.90%
|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant advancements in FDA approvals and intellectual property, alongside positive clinical outcomes and a solid cash position. However, revenue growth was minimal, and the company continues to operate at a loss with a decreased gross profit margin. While there are strong future growth potentials, current financial metrics present challenges.
Company Guidance
During the Tenon Medical First Quarter 2025 Financial Results and Corporate Update Conference Call, CEO Steve Foster and CFO Kevin Williamson provided guidance on the company's future prospects. The first quarter of 2025 saw a 1% increase in revenue to $726,000 compared to the same period in 2024, despite facing reimbursement pre-authorization challenges. Gross profit for the quarter was $323,000, representing 44% of revenue, a decline from 65% in the previous year due to variations in gross margin percentages. Operating expenses remained flat at $4 million, while the net loss was consistent with the previous year at $3.6 million. The company reported a cash balance of $10.3 million, bolstered by $7.1 million in gross proceeds from equity financing, with no outstanding debt. Looking forward, Tenon Medical anticipates growth driven by the upcoming commercial launch of the Catamaran SE platform and the second interim analysis of the MAINSAIL study. The company is focusing on commercial expansion, training programs, and completing the MAINSAIL trial, while expecting incremental revenue growth as reimbursement issues resolve and the sales force expands.
FDA Clearance for New Indication
The FDA cleared the Catamaran SI Joint Fusion System for an extended indication for use in augmenting thoracolumbar fusion. This expands the platform's versatility and opens a previously untapped market, potentially increasing adoption.
Strong Intellectual Property Portfolio
Received two European patents in the first quarter related to the Catamaran SI joint fixation device. The portfolio now includes 12 issued US and foreign patents, along with 31 pending applications.
Positive Clinical Outcomes
Interim analysis from the MAINSAIL study showed statistically significant reduction in SI joint pain and disability at six months, with a robust safety profile and high patient satisfaction.
Significant Cash Infusion
Received $7.1 million in gross proceeds from equity financing, contributing to a cash balance of $10.3 million, providing a strong runway for future growth initiatives.

Tenon Medical, Inc. (TNON) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TNON Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 2025
2025 (Q2)
-0.47 / -
-8.16
May 13, 2025
2025 (Q1)
-0.99 / -1.01
-1089.90% (+8.99)
Mar 20, 2025
2024 (Q4)
-3.77 / 10.53
3.76180.05% (+6.77)
Nov 13, 2024
2024 (Q3)
-6.16 / -3.63
-11.6868.92% (+8.05)
Aug 13, 2024
2024 (Q2)
-8.68 / -8.16
-26.469.09% (+18.24)
May 14, 2024
2024 (Q1)
-10.72 / -10.00
-34.470.93% (+24.40)
Mar 12, 2024
2023 (Q4)
-11.04 / 3.76
-56106.71% (+59.76)
Nov 14, 2023
2023 (Q3)
-22.40 / -11.68
-22.447.86% (+10.72)
Aug 08, 2023
2023 (Q2)
-30.40 / -26.40
-5249.23% (+25.60)
May 09, 2023
2023 (Q1)
-29.60 / -34.40
-190.481.93% (+156.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TNON Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 13, 2025
$1.24$1.11-10.48%
Mar 20, 2025
$1.11$1.00-9.91%
Nov 13, 2024
$3.30$2.81-14.85%
Aug 13, 2024
$4.68$3.72-20.51%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Tenon Medical, Inc. (TNON) report earnings?
Tenon Medical, Inc. (TNON) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
    What is Tenon Medical, Inc. (TNON) earnings time?
    Tenon Medical, Inc. (TNON) earnings time is at Aug 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TNON EPS forecast?
          TNON EPS forecast for the fiscal quarter 2025 (Q2) is -0.47.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis